Tags: Cancer | eczema | skin | cancer | risk | allergy | melanom

Eczema Sufferers Have Lower Skin Cancer Risk

By Nick Tate   |   Tuesday, 06 May 2014 04:09 PM

There may be an upside for people who suffer with eczema. New research shows the skin condition could reduce the risk of developing skin cancer.
Scientists with King's College London have discovered the immune-system response triggered by eczema could help prevent tumor formation by shedding potentially cancerous cells from the skin.
The study, involving experiments with mice and published in the journal eLife, is among the first to suggest that allergic reactions may in fact offer some protection against certain types of cancer.
"We are excited by our findings as they establish a clear link between cancer susceptibility and an allergic skin condition in our experimental model. They also support the view that modifying the body's immune system is an important strategy in treating cancer," said Fiona Watt, director of the Centre for Stem Cells and Regenerative Medicine.
"I hope our study provides some small consolation to eczema sufferers – that this uncomfortable skin condition may actually be beneficial in some circumstances."
Skin cancer accounts for one in every three cancers diagnosed worldwide, and the number of cases is rising, according to the World Health Organization.

© 2016 NewsmaxHealth. All rights reserved.

1Like our page
Eczema sufferers may have a reduced risk of developing skin cancer. British scientists have discovered the immune-system response triggered by eczema could help prevent tumor growth.
eczema, skin, cancer, risk, allergy, melanom

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved